Of note, in a recent cross-sectional analysis, with 28 patients with primary aldosteronism (PA), a major cause of secondary HTN, 14 patients with primary HTN, and 28 healthy controls, it was demonstrated that circulating endocan levels were significantly lower in the PA group, compared to the other groups [59]. Here, ESM1 is linked to hypertensive disorder.